The oxygen-labile hemolysin of Streptococcus pyogenes, or a substance having properties closely resembling those of this hemolysin, has an acute action on the isolated frog's heart (1). The most interesting feature of the action of this substance is that a single application of the toxin is essentially without effect on the heart, while a second application of the same preparation, given after washing the heart with two portions of Ringer's solution, results almost immediately in systolic standstill. That the phenomenon described consists of a true sensitization 1 of the heart to streptococcal toxin, and not of a simple summation of two subthreshold doses of the toxin, is shown by the fact that a single dose is without specific effect even when it is many times greater than the dose required to produce systolic contracture of a sensitized heart. The mechanism of the sensitization has been investigated and the results are reported in the present communication.
Demonstration that the Heart Releases an Inhibitor to SPA.--Exploratory
experiments indicated that the heart might release an SPA inhibitor in response to a single application of activated SPA. This possibility was tested in the following experiment:
Ringer's solution containing SPA in a concentration of 1:250 and cysteine in a concentration of 1:2500 was introduced into the Ftihner cannula. The only effect, as has previously been reported (1) , was a slight increase in amplitude of contraction. After 5 minutes, the 308 INHIBITION OF CARDIOTOXIC EFFECT fluid was removed from the heart, designated "A," and kept at room temperature. The heart was washed twice with Ringer's solution. After 10 minutes a solution containing SPA in a concentration of 1:125 and cysteine in a concentration of 1:1250 was mixed with an equal volume of "A," and the mixture applied to the heart. The solution had no effect other than a slight increase in amplitude of contraction. After 3 minutes, the fluid was removed and the heart was washed with two portions of Ringer's fluid. Application of a control solution containing SPA in a concentration of 1:250 and cysteine in a concentration of 1:2500 produced complete systolic standstill within 30 seconds (Fig. 1 ).
The experiment presented in Fig. 1 has been repeated numerous times, always with the same result, the release of an inhibitor. In order to determine whether the release is specifically associated with the administration of the first, or sensitizing, dose of activated SPA, the following solutions were tested for inhibitory activity: (1) Ringer's solution which had bathed normal hearts; (2) Cysteine 1:2500 in Ringer's solution; (3) Heatinactivated SPA 1:100 and cysteine 1:2500 in Ringer's solution. Each of these three solutions was applied to different hearts for 5 minutes, at the end of which time the solutions were removed from the hearts and tested. In no instance did these solutions, when mixed with a second dose of activated SPA, prevent the development of systolic contracture (Table I) .
The escape of an inhibitor from the heart upon application of the first dose of the toxin can account for the sensitization described in the preceding paper. If the sensitization of the heart to streptococcal toxin is dependent upon the release from the heart of an inhibitor, one would not expect to find released inhibitor from hearts which had undergone systolic standstill in response to the second dose of activated SPA. Fluid was removed from hearts that had undergone contracture in response to a second (or "contracturing") dose of SPA 1:250 with cysteine 1:2500, designated "B," and was tested in another heart for capacity to prevent the contracturing action of a solution of SPA in a final concentration of 1:250 with cysteine 1:2500. The solution designated "B" was found not to possess inhibitory activity.
In summary, the above experiments demonstrate conclusively that the heart responds to a single dose of SPA by releasing a substance which inhibits the Systolic contracture * Isolated frog's heart (Straub) sensitized to SPA by administration of Ringer's solution containing SPA 1: 250 and cysteine 1 : 2500, followed by washing with two portions of Ringer's solution.
:~ Normal heart washing indicates Ringer's solution which had bathed a normal isolated heart for 5 to 15 minutes.
§ Heated SPA indicates SPA heated to 70 ° C. for 10 minutes followed by administration (with cysteine 1 : 2500) to a normal isolated heart for 5 minutes.
action of the toxin. For convenience of presentation, the substance which inhibits systolic contracture will be referred to as "inhibitor," and the fluid containing it, "inhibitor fluid."
The capacity of the inhibitor fluid to prevent systolic contracture was measured by mixing a series of dilutions of inhibitor fluid with a constant contracturing dose of activated SPA, and by applying these mixtures ~o hearts previously sensitized. Although the potency of the inhibitor fluid from different hearts seemed to vary somewhat, in general the contracturing dose of SPA was inhibited by a fivefold but not by a tenfold dilution of the inhibitor fluid (Table I) . (6)) have demonstrated the existence of lethal factors in concentrated or unconcentrated filtrates and supernates of cultures of hemolytic streptococci. The preparation of SPA used in the present study was found to contain a lethal factor. When injected intravenously, 0.01 to 0.02 cc. of activated SPA caused mice weighing 16 to 20 gm. to die within 2 or 3 hours after injection. Death was frequently, but not always, preceded by the outpouring from the nostrils of hemoglobintinged fluid.
Neutralization of Lethal
In the preceding section it was shown that a substance released by the heart upon administration of SPA is capable of inhibiting the contracture-inducing 5 
§
* Mice which survived less than 5 minutes were counted as deaths. Unless otherwise noted mice which survived 5 minutes remained alive for the 1 week period during which they were kept under observation.
:~ 2 died overnight. § 3 died overnight.
action of the toxin. It was of interest to see whether the inhibitor fluid was capable of neutralizing the lethal activity of the SPA.
The test dose of activated SPA was that amount which uniformly killed 16 to 20 gm. mice within 5 minutes after intravenous injection, namely 0.5 cc. of a 1:25 dilution of SPA. Various amounts of inhibitor fluid from the frog's heart were mixed with a constant quantity of activated SPA, and the mixtures were injected intravenously into mice (Table II) . Of a total of 17 mice which received from 0.125 to 0.50 cc. of inhibitor fluid and 0.02 cc. of SPA in a final volume of 1 ce., 15 survived longer than 5 minutes. Of these 15, ten survived indefinitely. All of the eleven control mice which received no inhibitor died within 5 minutes.
The antilethal potency of the inhibitor fluid appeared to be of the same order as its capacity to protect against the cardiotoxic action of the SPA.
3. Properties of the Inhibitor.--In order to gain an insight into the chemical n a t u r e of t h e i n h i b i t o r , some of its p r o p e r t i e s were studied. I s o l a t e d h e a r t s were exposed to a single dose of S P A 1:100 to 1:250, a c t i v a t e d w i t h cysteine 1:2500, a n d a f t e r 5 m i n u t e s t h e fluid was r e m o v e d .
T h e q u a n t i t y of fluid o b t a i n e d f r o m each h e a r t was a p p r o x i m a t e l y 1.2 cc. T h e i n h i b i t o r fluid collected f r o m 8 to 12 h e a r t s was pooled a n d stored in t h e r e f r i g e r a t o r u n t i l used.
Heat Stability.--A tube containing several cubic centimeters of inhibitor fluid was immersed in water at 70 ° C. for 10 minutes. The capacity of the heated fluid to inhibit the Table II . Inhibition of contracturing action of SPA was tested in the manner of Table I . contracturing action of SPA was then compared to that of unheated inhibitor fluid. In addition to testing for inhibition of cardiotoxic action of SPA, the capacity of the heated inhibitor fluid to prevent the lethal action of SPA in mice was also tested. The results of this experiment are presented in Table III , in which it can be seen that heating to 70 ° C. for l0 minutes did not reduce the anticontracturing potency nor the antilethal action of inhibitor fluid. In similar experiments, more drastic treatment, namely heating the inhibitor fluid in boiling water for 30 minutes, did not reduce appreciably the anticardiotoxic action. The factor responsible for inhibition of SPA is therefore relatively heat-stable.
Non-Dialyzability.--3.S cc. of inhibitor fluid were dialyzed in a cellophane sac (Visking Corporation) against 7 cc. of Ringer's solution. Dialysis was carried out in the cold with occasional agitation over a period of 96 hours. At the end of this time, the anticardiotoxic action and the antflethal activity of the residue and of the dialysate were tested. All of the inhibitory activity was found to be present in the residue (Table III) . This experiment demonstrates that the inhibitor is non-dialyzable under the conditions stated.
INHIBITION 0~" CARDIOTOXIC EF~'ECT
Solubility in Chloroform.--3 cc. of inhibitor fluid were shaken at room temperature with five 3 co. portions of chloroform. A relatively large amount of precipitate formed at the chloroform-Ringer interface after extraction with the first portion of chloroform. The precipitate was separated, dissolved in saline solution, and tested for inhibitory activity. As this fraction failed to inhibit either the cardiotoxic or lethal actions of SPA, it was discarded. The combined chloroform extracts were concentrated to 1.5 co. in vacuo, and the concentrate was added dropwise to 3 co. of boiling saline solution. After adjusting the volume, the resulting suspension was tested in the frog's heart and in mice, and was found to inhibit both cardiotoxie action and lethal effect of SPA. The aqueous fraction remaining after chloroform extraction failed to inhibit either of these actions (Table III) . This experiment shows that the inhibitory activity can be recovered from the chloroform-soluble fraction.
DISCUSSION
The present results not only afford an explanation of the sensitization described in the preceding paper but in addition permit the formulation of the probable sequence of events which follows exposure of the isolated frog's heart to the streptococcal toxin. Although the administration of a single dose of diluted streptococcal toxin does not result in a persistent visible change in the functioning of the isolated frog's heart, it causes an effect the existence of which is not immediately obvious. This effect consists in the outpouring into the fluid which bathes the heart, of a substance which is capable of combining with the toxin, and of preventing further damage. The release of inhibitor is relatively rapid, and the quantity released by the heart is greatly in excess of that required to neutralize the toxin which is applied. Washing the toxintreated heart with two portions of Ringer's solution removes practically all of the inhibitor, and leaves an inhibitor-free organ whose state of reactivity differs markedly from that of the normal heart. Because it lacks the inhibitory substance, the "sensitized" heart responds acutely to the application of a second dose of streptococcal toxin; the response consists in the rapid development of systolic contracture.
The mechanism of the sensitization described is not without analogy. Clark (7) has shown that after perfusion for a few hours the excised frog's heart passes into a hypodynamic state. This condition is interpreted as being due to sensitization of the heart to Na and K ions present in the Ringer's solution, as can be seen by the prompt recovery of the heart upon decrease in the CK + -~-CNa+ of the perfusion fluid. In the hypodynamic condition, the Cca++ heart becomes more sensitive to alterations in the ionic balance of the perfusion fluid. The similarity between the sensitization investigated by Clark and that discussed here is further illustrated by the fact that in both cases the change in the state of the heart is associated with the loss of certain tissue constituents. In the case of the hypodynamic heart the constituents have been shown by Clark to be lipids; in the case described herein the constituents appear also to contain lipid. The two phenomena differ markedly, however, in the manner and rapidity with which the sensitized state is induced. The hypodynamic condition develops slowly and is apparent only after prolonged washing, while the sensitization caused by the streptococcal toxin develops in a matter of seconds.
The rapid liberation from the heart of a substance which inhibits the action of a bacterial toxin appears to have no counterpart in the well studied phenomena of immunity. The stability of the inhibitor toward heat and its solubility in chloroform are properties which clearly set it apart from antibody in the usual sense of the term. The present observations may find some analogy in the early observations of Pohl (8)~ Hueck (9), Waeker and Hueck (10) , and K6hler (11) on the type of immunity induced by the repeated injection into animals of sublethal doses of saponin. The increased saponin tolerance of animals treated in this manner, has been attributed to increased formation of cholesterol. SUMMARy 1. The mechanism of sensitization of the isolated frog's heart to a product of the hemolytic streptococcus has been investigated. The sensitization depends upon the release from the isolated heart of a substance which inhibits the action of the cardiotoxin. The inhibitor is released upon the first (sensitizing) administration of cardiotoxin, but not upon the second (contractureproducing) administration.
2. The inhibitor released by the heart neutralizes the lethal factor present in the streptococcal preparation employed.
3. Some of the properties of the inhibitor have been investigated. BIBLIOGRAPHY
